Patents by Inventor Chris Sander

Chris Sander has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160210399
    Abstract: The present invention relates to a method for predicting three-dimensional structure of a protein from its sequence. Three-dimensional structure may be determined by: (a) generating a multiple sequence alignment for a candidate protein having a known sequence; (b) identifying a covariance matrix between all pairs of sequence positions in the multiple sequence alignment; (c) inverting the covariance matrix and identifying predicted evolutionary constraints using a statistical model of the candidate protein; and (d) simulating folding of an extended chain structure of the candidate protein using the predicted constraints.
    Type: Application
    Filed: August 20, 2015
    Publication date: July 21, 2016
    Inventors: Chris Sander, Debora S. Marks
  • Publication number: 20160117440
    Abstract: In order to exploit vulnerabilities of cancer cells on the basis of homozygous deletion, a genomic profile of cancer cells in a biological sample is analyzed to identify homozygous deletions of one or more genes. The homozygous deletions, in turn, are analyzed in view of pathway data (e.g., metabolic, signaling, and/or cell-to-cell communication pathway data obtained from one or more databases) to determine a subset of homozygous deletions performing a function important to the viability of the cell. From this subset of homozygous deletions, cellular pathway data is analyzed to identify one or more partner genes (e.g., synthetic lethals) considered to facilitate or perform the same or similar function as the respective homozygous deletion. Drug annotations, in turn, may be reviewed to identify drugs that inhibit at least one of the synthetic lethal genes and/or gene products.
    Type: Application
    Filed: May 29, 2014
    Publication date: April 28, 2016
    Inventors: Bulent Arman AKSOY, Chris SANDER
  • Publication number: 20150345047
    Abstract: Methods and systems are presented herein for creating and using cell type-specific, quantitative network models of signaling in cells, such as melanoma, to predict cellular response to untested combinational perturbations. The methods involve performing a set of perturbation experiments with cells of a particular type to produce phosphoproteomic and/or phenotypic profiles for the cells; automatically extracting prior pathway information from one or more known databases to build a qualitative prior model; building a signaling pathway model from (i) the phosphoproteomic and/or phenotypic profiles produced from the perturbation experiments and (ii) the qualitative prior model from the known database(s); and performing in silico perturbations using the signaling pathway model to predict responses to a set of perturbation conditions not yet experimentally tested, and identifying one or more candidate drug combinations from the predicted responses.
    Type: Application
    Filed: May 27, 2015
    Publication date: December 3, 2015
    Inventors: Chris Sander, Anil Korkut
  • Publication number: 20150342960
    Abstract: Presented herein are methods of treating cancer, for example, RAFi-resistant melanoma, using a combination of a bromodomain inhibitor such as JQ1, together with either a MEK inhibitor (e.g., MEKi) or a BRAF inhibitor (e.g., RAFi). These combinations were identified from candidate combinations produced by a cell type-specific, quantitative network model of signaling in cells (e.g., melanoma) to predict cellular response to untested combinatorial perturbations.
    Type: Application
    Filed: May 27, 2015
    Publication date: December 3, 2015
    Inventors: Chris Sander, Anil Korkut
  • Publication number: 20150268248
    Abstract: The invention relates to a method for the Cell Type specific labeling with Amino acid Precursors (CTAP). In particular, the disclosed method permits the incorporation of stable isotope-labeled amino acids into the proteome of a vertebrate cell that has been engineered to express an exogenous enzyme that enables the cell to produce an essential amino acid from its amino acid substrate. The method employs stable isotope-labeled amino acid substrate/precursors from which essential amino acids bearing the label are generated. The labeled amino acids generated by the transgenic cell not only supports growth but specifically labels proteins of the transgenic cell. Furthermore, the use of different populations of cells expressing different exogenous amino acid-producing enzymes permits differential labeling of the proteomes of the individual cell populations in multicellular environments.
    Type: Application
    Filed: September 5, 2013
    Publication date: September 24, 2015
    Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Nicholas Gauthier, Chris Sander, Martin Miller
  • Publication number: 20130304432
    Abstract: The present invention relates to a method for predicting three-dimensional structure of a protein from its sequence. Three-dimensional structure may be determined by: (a) generating a multiple sequence alignment for a candidate protein having a known sequence; (b) identifying a covariance matrix between all pairs of sequence positions in the multiple sequence alignment; (c) inverting the covariance matrix and identifying predicted evolutionary constraints using a statistical model of the candidate protein; and (d) simulating folding of an extended chain structure of the candidate protein using the predicted constraints.
    Type: Application
    Filed: November 20, 2012
    Publication date: November 14, 2013
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Chris Sander, Debora S. Marks
  • Publication number: 20130303387
    Abstract: The present invention relates to a method for predicting three-dimensional structure of a protein from its sequence. Three-dimensional structure may be determined by: (a) generating a multiple sequence alignment for a candidate protein having a known sequence; (b) identifying a covariance matrix between all pairs of sequence positions in the multiple sequence alignment; (c) inverting the covariance matrix and identifying predicted evolutionary constraints using a statistical model of the candidate protein; and (d) simulating folding of an extended chain structure of the candidate protein using the predicted constraints.
    Type: Application
    Filed: May 9, 2013
    Publication date: November 14, 2013
    Inventors: Chris Sander, Debora S. Marks
  • Patent number: 8577619
    Abstract: Techniques for modeling living biological systems include receiving constant values for multiple interaction factors wij. A set of initial state values is received for state variables that indicate relevant properties of a living biological system. Also received is a set of trial values for perturbation variables that indicate factors that might affect one or more of the relevant properties of the biological system. A temporal change in a value for a particular state variable is determined based on a non-linear transformation of a sum of the trial value for the perturbation that affects the particular state added to a sum of all non-zero values for a product of wij and a state variable over all state variables. In some embodiments, measurement-based values are received for a measurable subset of the state variables. Values for the constant interaction factors wij are determined based on the measurement-based values.
    Type: Grant
    Filed: May 27, 2009
    Date of Patent: November 5, 2013
    Assignee: Sloan Kettering Institute for Cancer Research
    Inventors: Chris Sander, Sven Nelander, Wei Qing Wang, Peter Gennemark, Björn Nilsson
  • Patent number: 8544330
    Abstract: The embodiments of the probe or the probe handle additionally include an integrally formed cooling structure with at least one dividing wall that is connected to an outer wall and an inner wall of the probe. The outer wall and the inner wall of the probe together form a medium flow space inside the probe, and the dividing wall divides the medium flow space into a continuous medium flow path where a predetermined medium travels to carry undesirable heat away from the probe handle. The undesirable heat is generated from electronic components and or an array of transducer elements in the probe handle.
    Type: Grant
    Filed: September 9, 2010
    Date of Patent: October 1, 2013
    Assignees: Kabushiki Kaisha Toshiba, Toshiba Medical Systems Corporation
    Inventors: David Oaks, Chris Sanders
  • Publication number: 20110264420
    Abstract: Techniques for modeling living biological systems include receiving constant values for multiple interaction factors wij. A set of initial state values is received for state variables that indicate relevant properties of a living biological system. Also received is a set of trial values for perturbation variables that indicate factors that might affect one or more of the relevant properties of the biological system. A temporal change in a value for a particular state variable is determined based on a non-linear transformation of a sum of the trial value for the perturbation that affects the particular state added to a sum of all non-zero values for a product of wij and a state variable over all state variables. In some embodiments, measurement-based values are received for a measurable subset of the state variables. Values for the constant interaction factors wij are determined based on the measurement-based values.
    Type: Application
    Filed: May 27, 2009
    Publication date: October 27, 2011
    Inventors: Chris Sander, Sven Nelander, Wei Qing Wang, Peter Gennemark, Bjorn Nilsson
  • Patent number: 7929964
    Abstract: Managing wireless fidelity communications for a mobile station includes automatically activating and deactivating wireless fidelity communication capability on the mobile station. Whenever wireless fidelity communications are not active, the wireless fidelity capability is turned off until at least one of a plurality of preselected triggering events occurs. If at least one of the triggering events occurs, a wireless fidelity probing mode begins and a wireless fidelity communication connection is established if one is available.
    Type: Grant
    Filed: June 8, 2007
    Date of Patent: April 19, 2011
    Assignee: Alcatel-Lucent USA Inc.
    Inventors: Gil Arumi, Henry Chor, Chris Sanders
  • Patent number: 7925268
    Abstract: Techniques are provided herein to optimize up-link transmission power from a wireless terminal to a base transceiver station in a multicarrier system. A pathloss between the wireless terminal and the base transceiver station is determined. A determination is made if the pathloss is less than or larger than a predetermined value. One or more sub-carriers are assigned to the wireless terminal based on whether the pathloss between the wireless terminal and the base transceiver station is less than or larger than the predetermined value. A power cap command signal is sent from the base transceiver station to the wireless terminal for limiting a maximum allowable power transmitted by the wireless terminal to a predetermined level based on proximity of the one or more sub-carriers to an edge of a frequency band used for up-link transmissions made by the wireless terminal.
    Type: Grant
    Filed: August 11, 2006
    Date of Patent: April 12, 2011
    Assignee: Cisco Technology, Inc.
    Inventors: Chris Sanders, Santhalingam Balasekar, Hang Jin, John Grabner, Tuyen Banh
  • Publication number: 20080305786
    Abstract: Managing wireless fidelity communications for a mobile station includes automatically activating and deactivating wireless fidelity communication capability on the mobile station. Whenever wireless fidelity communications are not active, the wireless fidelity capability is turned off until at least one of a plurality of preselected triggering events occurs. If at least one of the triggering events occurs, a wireless fidelity probing mode begins and a wireless fidelity communication connection is established if one is available.
    Type: Application
    Filed: June 8, 2007
    Publication date: December 11, 2008
    Inventors: Gil Arumi, Henry Chor, Chris Sanders
  • Publication number: 20070060190
    Abstract: A method for optimizing up-link transmission power from a wireless terminal to a base transceiver station in a multi-carrier system is disclosed. The method includes steps of: determining a pathloss between the wireless terminal and the base transceiver station; assigning at least one sub-carrier to the terminal based on the pathloss between the wireless terminal and the base transceiver station; and sending a power cap command signal from the base transceiver station to the wireless terminal for limiting a maximum allowable power transmitted by the wireless terminal to a predetermined level based on proximity of the sub-carrier to an edge of a frequency band, over which the wireless terminal transmits and receives signals.
    Type: Application
    Filed: August 11, 2006
    Publication date: March 15, 2007
    Inventors: Chris Sanders, Santhalingam Balasekar, Hang Jin, John Grabner, Tuyen Banh
  • Patent number: PP27333
    Abstract: A new cultivar of Dasiphora, ‘LISSDAN’, that is characterized by its upright, bushy plant form, its single flowers with the upper surface of the petals bright cerise to fuchsia pink in color and the lower surface of the petals pale cream to parchment in color, and its flowers that retain their color throughout the blooming season.
    Type: Grant
    Filed: July 14, 2014
    Date of Patent: November 1, 2016
    Inventor: Chris Sanders